|
PRKACB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.280100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.359100E-03 |
| Normal-vs-Stage2 |
2.272400E-01 |
| Normal-vs-Stage3 |
9.520400E-03 |
| Normal-vs-Stage4 |
4.696100E-02 |
| Stage1-vs-Stage2 |
6.575600E-01 |
| Stage1-vs-Stage3 |
3.014800E-01 |
| Stage1-vs-Stage4 |
5.666200E-01 |
| Stage2-vs-Stage3 |
2.204400E-01 |
| Stage2-vs-Stage4 |
3.104200E-01 |
| Stage3-vs-Stage4 |
9.171400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.599000E-03 |
| Normal-vs-AfricanAmerican |
2.997800E-02 |
| Normal-vs-Asian |
4.763400E-01 |
| Caucasian-vs-AfricanAmerican |
7.452400E-01 |
| Caucasian-vs-Asian |
9.282600E-01 |
| AfricanAmerican-vs-Asian |
8.234600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.604000E-03 |
| Normal-vs-Female |
1.135580E-01 |
| Male-vs-Female |
4.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.774900E-04 |
| Normal-vs-Extreme_Weight |
7.775800E-02 |
| Normal-vs-Obese |
3.859800E-02 |
| Normal-vs-Extreme_Obese |
2.424800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.655390E-01 |
| Normal_Weight-vs-Obese |
2.194000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.291400E-01 |
| Extreme_Weight-vs-Obese |
8.734000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.472200E-01 |
| Obese-vs-Extreme_Obese |
8.885600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.624000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.095200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.037500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.542400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.375640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.438000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.606400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.517600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.961630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.738600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.039800E-01 |
| Normal-VS-Type2 PRCC |
1.30009999987912E-07 |
| Normal-VS-KIRP CIMP |
2.194800E-04 |
| Normal-VS-Unclassified PRCC |
2.014600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.56644999999012E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.099200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.126200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.041000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.236390E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.978000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.436600E-04 |
| Normal-vs-N1 |
7.611100E-04 |
| Normal-vs-N2 |
1.841850E-02 |
| N0-vs-N1 |
5.494800E-01 |
| N0-vs-N2 |
8.697400E-01 |
| N1-vs-N2 |
9.007600E-01 |
|
|
